Optimal starting age of endoscopic screening for esophageal cancer in China: A multicenter prospective cohort study

Ru Chen,Lizhou Dou,Jiachen Zhou,Guohui Song,Bianyun Li,Deli Zhao,Zhaolai Hua,Xinzheng Wang,Jun Li,Changqing Hao,Yanyan Li,Xiang Feng,Lin Li,Wenqiang Wei,Guiqi Wang
DOI: https://doi.org/10.1002/cam4.5727
IF: 4.711
2023-04-09
Cancer Medicine
Abstract:Compared with the unscreened group, initiation of screening after 50 years was associated with a greater reduction in cumulative incidence and mortality in 10 years follow‐up compared with initiation before 50 years. Background Although endoscopic screening for esophageal cancer has been performed in high‐risk areas in China for decades, there is limited and inconsistent evidence regarding the starting age for individuals participating in screening. The aim of this study is to investigate the optimal starting age of esophageal cancer screening. Methods This study is based on a multicenter prospective cohort consisting 338,017 permanent residents aged 40–69 years in six high‐risk areas of esophageal cancer in China. The participation rate, detection rate, hazard ratios (HRs), cumulative incidence and mortality and number needed to screen (NNS) were calculated in each age group. Screening burden, benefit and risk were compared among screening strategies with different initiation ages to explore the optimal starting age for population‐based screening in high‐risk areas. Results Individuals aged 50–69 had a higher participation rate, a higher detection rate and improved screening effectiveness than those aged 40–49. The endoscopic screening had no significant effect on reducing the incidence of esophageal cancer in individuals under 55 and mortality in individuals under 45. Increasing the starting age to 50 years reduced the screening demand and NNS by 40% and 55%, and resulted in 12% of detectable positive cases, 16% of preventable incident cases, and 14% of preventable deaths being missed. Conclusions Postponing the starting age of endoscopic screening to 50 years might yield a more‐favorable balance between screening benefit and burden in high‐ risk areas with limited resources.
oncology
What problem does this paper attempt to address?